R1 hepatectomy with exposure of tumor surface for centrally located hepatocellular carcinoma
- PMID: 24370545
- DOI: 10.1007/s00268-013-2429-3
R1 hepatectomy with exposure of tumor surface for centrally located hepatocellular carcinoma
Abstract
Background: Hepatectomy with exposure of tumor surface (a special type of R1 resection) provides a chance of cure for selected patients with centrally located hepatocellular carcinoma (HCC) that is adherent to or compresses major vessels. However, the operative indications, safety, and patient outcomes are not well defined.
Methods: We performed hepatectomy for removal of complex centrally located HCC using a selective and dynamic region-specific vascular occlusion technique. Between May 2006 and March 2012, a total of 118 patients underwent resection with exposure of tumor surface (exposure group) and 169 underwent conventional hepatectomy (without exposure of the tumor and vascular surface). The short- and long-term outcomes of patients were evaluated and compared.
Results: The postoperative recovery of liver function was comparable between the two groups. Bile leakage occurred in five patients, all in the exposure group. The 1-, 3-, and 5-year recurrence-free survival rates were 74.4, 45.6, and 30.1 % in the exposure group and 80.9, 57.2, and 31.7 % in the control group (p = 0.041). Corresponding overall survival rates were 92.3, 70.3, and 44.9 % in the exposure group and 97.8, 81.4, and 53.1 % in the control group (p = 0.094).
Conclusions: Hepatectomy with exposure of tumor surface is technically demanding, but can be performed safely. It is also associated with a risk of tumor recurrence. Multidisciplinary combined therapy would be the solution and can contribute to improve overall survival.
Similar articles
-
Mesohepatectomy versus extended hemihepatectomy for centrally located hepatocellular carcinoma.Hepatobiliary Pancreat Dis Int. 2014 Jun;13(3):264-70. doi: 10.1016/s1499-3872(14)60253-8. Hepatobiliary Pancreat Dis Int. 2014. PMID: 24919609
-
Treatment of centrally located hepatocellular carcinoma with central hepatectomy.Surgery. 2003 Mar;133(3):251-6. doi: 10.1067/msy.2003.102. Surgery. 2003. PMID: 12660635
-
Is R1 vascular hepatectomy for hepatocellular carcinoma oncologically adequate? Analysis of 327 consecutive patients.Surgery. 2019 May;165(5):897-904. doi: 10.1016/j.surg.2018.12.002. Epub 2019 Jan 26. Surgery. 2019. PMID: 30691871
-
Central hepatectomy versus major hepatectomy for patients with centrally located hepatocellular carcinoma: A meta-analysis.Int J Surg. 2018 Apr;52:297-302. doi: 10.1016/j.ijsu.2018.02.059. Epub 2018 Mar 9. Int J Surg. 2018. PMID: 29530828 Review.
-
Central hepatectomy versus major hepatectomy for patients with centrally located hepatocellular carcinoma: a systematic review and meta-analysis.BMC Surg. 2023 Jan 5;23(1):2. doi: 10.1186/s12893-022-01891-7. BMC Surg. 2023. PMID: 36600282 Free PMC article.
Cited by
-
Prognostic Factors and Clinical Characteristics for Hepatocellular Carcinoma Patients with Benign Enlarged Perihepatic Lymph Nodes: a Single-Center Experience from China.J Gastrointest Surg. 2015 Oct;19(10):1822-32. doi: 10.1007/s11605-015-2900-6. Epub 2015 Aug 11. J Gastrointest Surg. 2015. PMID: 26259664
-
Three-dimensional morphometric analysis for hepatectomy of centrally located hepatocellular carcinoma: a pilot study.World J Gastroenterol. 2015 Apr 21;21(15):4607-19. doi: 10.3748/wjg.v21.i15.4607. World J Gastroenterol. 2015. PMID: 25914470 Free PMC article.
-
Intensity-modulated radiotherapy following null-margin resection is associated with improved survival in the treatment of intrahepatic cholangiocarcinoma.J Gastrointest Oncol. 2015 Apr;6(2):126-33. doi: 10.3978/j.issn.2078-6891.2014.102. J Gastrointest Oncol. 2015. PMID: 25830032 Free PMC article.
-
Clinical benefits of intraoperative radiotherapy for the recurrence of centrally located hepatocellular carcinoma with microvascular invasion.Cancer Rep (Hoboken). 2024 Jan;7(1):e1928. doi: 10.1002/cnr2.1928. Epub 2023 Oct 31. Cancer Rep (Hoboken). 2024. PMID: 37906430 Free PMC article.
-
Long-term outcome of adjuvant radiotherapy upon postoperative relapse of centrally located hepatocellular carcinoma: a real-world study.Sci Rep. 2024 Apr 12;14(1):8506. doi: 10.1038/s41598-024-59180-7. Sci Rep. 2024. PMID: 38605164 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical